Variations in lung cancer risk among smokers.

BACKGROUND Although there is no proven benefit associated with screening for lung cancer, screening programs are attracting many individuals who perceive themselves to be at high risk due to smoking. We sought to determine whether the risk of lung cancer varies predictably among smokers. METHODS We used data on 18 172 subjects enrolled in the Carotene and Retinol Efficacy Trial (CARET)-a large, randomized trial of lung cancer prevention-to derive a lung cancer risk prediction model. Model inputs included the subject's age, sex, asbestos exposure history, and smoking history. We assessed the model's calibration by comparing predicted and observed rates of lung cancer across risk deciles and validated it by assessing the extent to which a model estimated on data from five CARET study sites could predict events in the sixth study site. We then applied the model to evaluate the risk of lung cancer among smokers enrolled in a study of lung cancer screening with computed tomography (CT). RESULTS The model was internally valid and well calibrated. Ten-year lung cancer risk varied greatly among participants in the CT study, from 15% for a 68-year-old man who has smoked two packs per day for 50 years and continues to smoke, to 0.8% for a 51-year-old woman who smoked one pack per day for 28 years before quitting 9 years earlier. Even among the subset of CT study participants who would be eligible for a clinical trial of cancer prevention, risk varied greatly. CONCLUSIONS The risk of lung cancer varies widely among smokers. Accurate risk prediction may help individuals who are contemplating voluntary screening to balance the potential benefits and risks. Risk prediction may also be useful for researchers designing clinical trials of lung cancer prevention.

[1]  M. O. Lorenz,et al.  Methods of Measuring the Concentration of Wealth , 1905, Publications of the American Statistical Association.

[2]  B. Efron,et al.  A Leisurely Look at the Bootstrap, the Jackknife, and , 1983 .

[3]  J. Lubin,et al.  Modifying risk of developing lung cancer by changing habits of cigarette smoking. , 1984, British medical journal.

[4]  R. Peto Influence of dose and duration of smoking on lung cancer rates. , 1986, IARC scientific publications.

[5]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[6]  J. Samet The health benefits of smoking cessation. , 1991, The Medical clinics of North America.

[7]  A. Miller,et al.  Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. , 1993, American journal of epidemiology.

[8]  H. Anton-Culver,et al.  Sex differences in lung‐cancer risk associated with cigarette smoking , 1993, International journal of cancer.

[9]  E. Wynder,et al.  Race and sex differences in lung cancer risk associated with cigarette smoking. , 1993, International journal of epidemiology.

[10]  B. Gillespie,et al.  Patterns of absolute risk of lung cancer mortality in former smokers. , 1993, Journal of the National Cancer Institute.

[11]  G. Omenn,et al.  The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. , 1994, Cancer research.

[12]  M. Thun,et al.  Excess mortality among cigarette smokers: changes in a 20-year interval. , 1995, American journal of public health.

[13]  W. D. Ray 4. Modelling Survival Data in Medical Research , 1995 .

[14]  E. Wynder,et al.  Differences in lung cancer risk between men and women: examination of the evidence. , 1996, Journal of the National Cancer Institute.

[15]  G. Omenn,et al.  Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.

[16]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[17]  J S Lee,et al.  Clonal genetic alterations in the lungs of current and former smokers. , 1997, Journal of the National Cancer Institute.

[18]  M Schumacher,et al.  Resampling and cross-validation techniques: a tool to reduce bias caused by model building? , 1997, Statistics in medicine.

[19]  E. Fearon The smoking gun and the damage done: genetic alterations in the lungs of smokers. , 1997, Journal of the National Cancer Institute.

[20]  A Sundin,et al.  Identification of human brain loci processing esophageal sensation using positron emission tomography. , 1997, Gastroenterology.

[21]  J. Vestbo,et al.  Gender and Smoking‐Related Risk of Lung Cancer , 1998, Epidemiology.

[22]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[23]  C. Hertzman,et al.  Fertility among a Cohort of Male Sawmill Workers Exposed to Chlorophenate Fungicides , 1998, Epidemiology.

[24]  W. Black,et al.  Advances in radiology and the real versus apparent effects of early diagnosis. , 1998, European journal of radiology.

[25]  N. Weiss,et al.  Menopausal hormone use and endometrial cancer, by tumor grade and invasion. , 1998, Epidemiology.

[26]  M. Goldberg,et al.  Lung cancer and indoor air pollution arising from Chinese-style cooking among nonsmoking women living in Shanghai, China. , 1999, Epidemiology.

[27]  C. Heath,et al.  Smoking cessation and mortality trends among 118,000 Californians, 1960-1997. , 1999, Epidemiology.

[28]  G. Bepler Lung cancer epidemiology and genetics. , 1999, Journal of thoracic imaging.

[29]  K. Covinsky,et al.  Assessing the Generalizability of Prognostic Information , 1999, Annals of Internal Medicine.

[30]  M. Thun,et al.  Epidemiological research at the American Cancer Society. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[31]  W C Black,et al.  Overdiagnosis: An underrecognized cause of confusion and harm in cancer screening. , 2000, Journal of the National Cancer Institute.

[32]  Inger,et al.  A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.

[33]  W. Ahrens,et al.  Gender differences in lung cancer risk by smoking: a multicentre case–control study in Germany and Italy , 1999, British Journal of Cancer.

[34]  M. Kogevinas,et al.  Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. , 2000, Mutation research.

[35]  G. Bepler,et al.  Screening for lung cancer. , 2000, The New England journal of medicine.

[36]  C. Henschke Early lung cancer action project , 2000, Cancer.

[37]  Spratt Js,et al.  Assessing the risk of breast cancer. , 2000 .

[38]  Frank E. Harrell,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .

[39]  T. Perneger Sex, smoking, and cancer: a reappraisal. , 2001, Journal of the National Cancer Institute.

[40]  C B Begg,et al.  The search for cancer risk factors: when can we stop looking? , 2001, American journal of public health.

[41]  D. Schrag,et al.  Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. , 2001, Blood.

[42]  T. Brennan,et al.  Direct-to-consumer marketing of high-technology screening tests. , 2002, The New England journal of medicine.

[43]  S. Swensen,et al.  Screening for lung cancer with low-dose spiral computed tomography. , 2000, American journal of respiratory and critical care medicine.

[44]  Lisa M. Schwartz,et al.  Risk charts: putting cancer in context. , 2002, Journal of the National Cancer Institute.

[45]  Douglas C McCrory,et al.  Screening for lung cancer: a review of the current literature. , 2003, Chest.